Recall D-0506-2026

US Class II Ongoing · initiated 2026-04-01

Recalling firm

Wells Pharma of Houston LLC, TX

Product

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

Reason for recall

cGMP deviations.

← All recalls